Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.9%

4 terminated out of 58 trials

Success Rate

89.7%

+3.2% vs benchmark

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

6%

2 of 35 completed with results

Key Signals

2 with results90% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (22)
P 1 (2)
P 2 (6)
P 3 (1)
P 4 (2)

Trial Status

Completed35
Unknown7
Recruiting6
Terminated4
Not Yet Recruiting3
Active Not Recruiting2

Trial Success Rate

89.7%

Benchmark: 86.5%

Based on 35 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT06114264Not ApplicableCompleted

Multimodal Intervention in Patients With Non-specific Chronic Low Back Pain: the HEALTHY BACK Project

NCT03964272Not ApplicableCompleted

A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD

NCT06655025Not ApplicableCompleted

The Effects of Dexmedetomidine on Postoperative Cognitive Function in Open Heart Surgery

NCT06387290Phase 3Recruiting

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

NCT07340775Not ApplicableNot Yet Recruiting

Hypersensitivity to Amylin in Post-Traumatic Headache

NCT07340788Not ApplicableNot Yet Recruiting

Amylin-Induced Migraine Attacks Without Aura

NCT07258290Not ApplicableNot Yet Recruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT04289142Phase 4Recruiting

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients

NCT03749538Not ApplicableRecruiting

Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

NCT06245694Recruiting

Predictive and Advanced Analytics in Emergency Medicine - Neurological Deficits

NCT04937452Phase 2Completed

Dopaminergic Therapy for Frontotemporal Dementia Patients

NCT03913130Phase 1Terminated

Extension Study to Study PQ-110-001 (NCT03140969)

NCT05657860Phase 4Completed

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome

NCT06512636CompletedPrimary

A Decade-Long Dance With Diplopia: Unraveling the Enigma of Recurrent 6th Nerve Palsy

NCT04800809Completed

The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria

NCT05475769Recruiting

NUMITOR Study: Nummular Headache Iberian Study on the Treatments and Outcomes in Real-World Setting

NCT06264050Not ApplicableActive Not Recruiting

Psychological Support Group and Its Effects on Mood, Anxiety and Coping

NCT04362930CompletedPrimary

Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences)

NCT04568707Not ApplicableCompleted

Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

NCT02431780Not ApplicableCompleted

A Multicentre Clinical Investigation of a Decision Support Algorithm for Neonatal Seizure Detection

Scroll to load more

Research Network

Activity Timeline